# LLM Judge Evaluation: tier1_007

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 1/6

### Reasoning:
- Completion: The agent never produced a numerical pKa for any amine in semaglutide. They stopped after two molecule_lookup calls and asked the user for a SMILES, so the workflow did not finish.
- Correctness: No value was computed. In addition, the agent targeted the Lys ε-amine, which in semaglutide is acylated (converted to an amide) and therefore is not a basic amine site. The only free primary amine in semaglutide is the N‑terminal α‑amine on His1; typical pKa values for N‑terminal His α‑amines in peptides are around 7.6–7.9 based on experimental measurements in related peptides (e.g., glucagon, VIP). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26308095/?utm_source=openai))
- Tool use: The agent used only a name/CAS lookup and did not retrieve readily available structural information (e.g., PubChem/DrugBank) nor proceed to any pKa computation. Requesting the user’s SMILES was unnecessary, and targeting a non-existent “free” Lys ε‑amine indicates a conceptual misidentification of the protonation site.

### Feedback:
- Identify the correct protonation site first: in semaglutide the Lys26 ε‑amine is acylated (amide), so the relevant “amine” pKa is the N‑terminal α‑amine on His1.
- Don’t block on SMILES: retrieve structure/sequence from PubChem or DrugBank using CAS/name, then map modifications to confirm titratable sites. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26308095/?utm_source=openai))
- If experimental pKa for the exact peptide is unavailable, cite closely related experimental systems (e.g., N‑terminal His in glucagon/VIP) and, if needed, provide a computed estimate (e.g., PROPKA/constant‑pH MD) with clear assumptions and site specification. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai))
- Literature validation: 1) Agent’s computed value: none provided.

2) Literature value(s) to anchor expectations:
- Semaglutide’s Lys26 is acylated with a C18 diacid via a γ‑Glu and two AEEA linkers; thus the Lys ε‑nitrogen is an amide, not an amine (not titratable as a basic amine). ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00726?utm_source=openai))
- The only free primary amine in semaglutide is the N‑terminal α‑amine (His1). Experimental pKa for the α‑amino group of N‑terminal His in peptides has been measured at:
  • 7.60 ± 0.04 (glucagon, N‑terminal His) and
  • 7.88 ± 0.18 (VIP, N‑terminal His). 
  These values provide a reasonable experimental bracket for semaglutide’s N‑terminal α‑amine. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai))
- The semaglutide sequence confirming N‑terminal His and Lys26 acylation is reported by peptide vendors and structural resources (useful for site identification). ([cpcscientific.com](https://cpcscientific.com/semaglutide/?utm_source=openai))

3) Absolute error: N/A (no agent value).

4) Percent error: N/A.

5) Score justification: No numerical result to compare; additionally, the targeted functional group (Lys ε‑amine) is not present as a basic amine in semaglutide, so even a computed value for that site would have been conceptually incorrect. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00726?utm_source=openai))

### Web Search Citations:
1. [Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide - PubMed](https://pubmed.ncbi.nlm.nih.gov/26308095/?utm_source=openai)
2. [Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide | Journal of Medicinal Chemistry](https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00726?utm_source=openai)
3. [Unusual chemical properties of N-terminal histidine residues of glucagon and vasoactive intestinal peptide](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai)
4. [Semaglutide - CPC Scientific](https://cpcscientific.com/semaglutide/?utm_source=openai)
5. [Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide | Journal of Medicinal Chemistry](https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00726?utm_source=openai)
6. [Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide - PubMed](https://pubmed.ncbi.nlm.nih.gov/26308095/?utm_source=openai)
7. [Unusual chemical properties of N-terminal histidine residues of glucagon and vasoactive intestinal peptide](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai)

### Execution:
- **Tools**: molecule_lookup
- **Time**: 1.3 min

---
*Evaluated with openai/gpt-5*
